Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Biosensor Detects Antibiotic Resistant Bacteria

By LabMedica International staff writers
Posted on 21 May 2013
Antibody conjugated latex beads have been utilized to create a biosensor designed for discrimination of methicillin resistant (MRSA) and sensitive (MSSA) Staphylococcus aureus species.

The technology takes advantage of bacteriophages, simple viruses that can target and kill bacteria, and when combined with specific antibodies, can be used to produce a physical color change in a sample that indicates antibiotic resistance.

Scientists at Auburn University (AL, USA) collaborated with those at the Clinical Research Laboratory, Keesler Air Force Base (Biloxi, MS, USA) developed a biosensor to specifically detect and identify MRSA utilizing a device with a two-step action. More...
The bacteriophage 12600 can be utilized as a recognition probe for S. aureus strains including those having methicillin resistance.

The S. aureus bacteriophage has a wide spectrum of hosts, including MRSA strains, was combined with a monoclonal antibody against penicillin-binding protein 2a (PBP 2a). The initial step used a S. aureus bacteriophage monolayer as a sensor probe, while the second step employed PBP 2a specific antibodies. The first step will recognize S. aureus bacteria, as the other one will be sensitive to the antibiotic-binding protein. When signals received from two steps are positive, it indicates the specific detection of MRSA. The method described in this study is rapid, does not need DNA extraction, and it is not sensitive to admixtures.

Vitaly Vodyanoy, MS, PhD, the senior author of the study said, “In our method, we can determine bacterial antibiotic resistance in 10 to 12 minutes, while other methods take hours. Alternative methods used to detect antibiotic resistance need time-intensive purification steps before multihour sequencing protocols. We envision a future where clinicians do tests with real blood or saliva samples. The virus is completely benign to humans, and we hope to use it to make antimicrobial surfaces and glassware that kill the bacteria." The study was published on May 8, 2013, in the Journal of Visualized Experiments.

Related Links:

Auburn University
Keesler Air Force Base



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Automated Urinalysis Solution
UN-9000
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: The duet mosaic family comprises duet +modC mosaic and duet 6-base mosaic, two cfDNA-optimized multiomic sequencing workflows for liquid biopsy and translational research. (Photo courtesy of bimodal)

New Liquid Biopsy Workflow Maximizes Tumor Signals from Limited Blood Samples

Liquid biopsy seeks to detect tumor-derived signals from small blood samples, but circulating cell-free DNA is scarce and heterogeneous, limiting sensitivity. Combining complementary signals such as methylation,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.